Medical Devices
Bringing a medical device to market means MDR 2017/745, IVDR, FDA 510(k)/PMA, PMDA, NMPA, UDI, ISO 13485, ISO 14971, and clinical evaluation — for every class, every market. Cleo maps each certification, declaration, and post-market surveillance obligation per device per country, so your regulatory team ships faster and stays audit-ready.
Cleo maps regulatory obligations for medical devices across 106 countries.
Launching a medical device across the EU, US, Japan, China, Brazil, and Korea means EU MDR 2017/745, IVDR 2017/746, FDA 21 CFR Part 820, 510(k)/PMA/De Novo, PMDA shōnin, NMPA registration, ANVISA RDC 751/2022, and MFDS approvals — each with different classification rules, clinical evidence requirements, and UDI conventions. Cleo builds a complete compliance matrix per device class per market, with classification guidance, clinical evaluation gap analysis, and certification timelines.
See how medical devices compliance varies across jurisdictions.

See how Cleo maps regulations and screens third parties, in minutes, not months.